Steven Daniel joins Cofactor Genomics as Vice President of Business Development
San Francisco, June 20, 2019 -- Cofactor Genomics today announced the appointment of Steven Daniel, PhD, as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management. Dr. Daniel comes to Cofactor from ...
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
San Francisco, June 4, 2019 --Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing the adoption of ...
Cofactor Genomics to provide solid tumor immune profiling for Genocea Biosciences
San Francisco, December 4, 2018 -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s ImmunoPrismTM assay in Genocea Biosciences’ Phase 1/2a clinical trial testing the safety and efficacy ...